lcq908
Showing 1 - 8 of 8
Hyperlipoproteinemia Trial in Quebec (LCQ908, Placebo)
Completed
- Hyperlipoproteinemia
- LCQ908
- Placebo
-
Quebec, CanadaNovartis Investigative Site
Dec 11, 2020
Hepatic Impairment Trial in Miami, Orlando (LCQ908)
Completed
- Hepatic Impairment
- LCQ908
-
Miami, Florida
- +1 more
Dec 16, 2020
Renal Impairment Trial in Orlando, Knoxville (LCQ908)
Completed
- Renal Impairment
- LCQ908
-
Orlando, Florida
- +1 more
Dec 16, 2020
Non Familial Chylocmicronemia Syndrome (Non-FCS) Trial in Canada, Russian Federation, United States (LCQ908, Fenofibrate, Fish
Completed
- Non Familial Chylocmicronemia Syndrome (Non-FCS)
- LCQ908
- +5 more
-
Muscle Shoals, Alabama
- +31 more
Dec 11, 2020
Familial Chylomicronemia Syndrome (FCS) (HLP Type I) Trial in Worldwide (LCQ908)
Terminated
- Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
- LCQ908
-
Seatlle, Washington
- +9 more
Sep 26, 2016
Non-alcoholic Fatty Liver Disease (NAFLD) Trial in United States (LCQ908, )
Completed
- Non-alcoholic Fatty Liver Disease (NAFLD)
- LCQ908
- placebo
-
Mobile, Alabama
- +10 more
Jan 5, 2016
Familial Chylomicronemia Syndrome (FCS) Trial in Worldwide (LCQ908, Placebo)
Completed
- Familial Chylomicronemia Syndrome (FCS)
- LCQ908
- Placebo
-
Seatlle, Washington
- +13 more
May 15, 2015
Hepatitis C Trial in Auckland, Christchurch (LCQ908, Placebo)
Terminated
- Hepatitis C
- LCQ908
- Placebo
-
Auckland, New Zealand
- +1 more
May 6, 2012